Shows
OIS Podcast | Ophthalmology's leading PodcastTransforming Myopia Treatment: Perry Sternberg Talks SYD-101This week on The Rob & Jai Show, an edition of the OIS Podcast, Perry Sternberg, CEO of Sydnexis, discusses the company's efforts to bring its innovative SYD-101 product to market, which aims to slow the progression of pediatric myopia.Challenges in Market Access: Sternberg emphasizes the challenges of market access and reimbursement, explaining that it's not just about the product’s price but also the value proposition it offers.Launch Plans for 2026: The company is planning for a 2026 launch, following FDA approval, with a strong focus on ensuring a positive experience for both physicians an...
2025-05-0938 min
OIS Podcast | Ophthalmology's leading PodcastUnlocking the Uveoscleral Pathway: Adam Szaronos on Bio-Interventional Innovation in GlaucomaIn this edition of The Rob & Jai Show, the OIS Podcast welcomes Adam Szaronos, CEO of IanTrek, for a wide-ranging conversation on innovation, leadership, and unlocking new pathways in glaucoma care. Adam walks us through his career journey from Alcon to TearLab to leading IanTrek, where he’s now championing a new class of glaucoma procedures with AloeFlow™—a minimally invasive, tissue-based implant that activates the uveoscleral pathway.Together with hosts Dr. Rob Rothman and Dr. Jai Parekh, Adam discusses:The evolution of his career from medical device sales to surgical commercialization and C-suite leadership.Why the uv...
2025-04-2538 min
OIS Podcast | Ophthalmology's leading PodcastBringing Presbyopia Back to the Forefront: Paul Smith of Orasis on The Rob & Jai Show, an Edition of the OIS PodcastIn this edition of The Rob & Jai Show, Paul Smith, President & COO of Orasis Pharmaceuticals, joins Dr. Rob Rothman and Dr. Jai Parekh for a compelling conversation on his career path and the commercialization of Qlosi™—a novel, FDA-approved, low-dose pilocarpine eye drop for the treatment of presbyopia.With more than two decades of experience across Alcon, Novartis, and now Orasis, Smith reflects on his unique career trajectory from tech startups to ophthalmic leadership, the importance of cross-functional experience, and how a shared vision with founder & CEO Elad Kedar led him to the helm of a company now...
2025-04-1136 min
OIS Podcast | Ophthalmology's leading PodcastThe View from the Street: Industry Trends, Strategic Shifts & Navigating UncertaintyIn this edition of the OIS Podcast, a powerhouse panel of investment, banking, and biotech leaders offers unfiltered insights on the current and future state of the ophthalmic industry. Featuring Andrew Gitkin (Leerink Partners), Cameron Taylor (Bank of America), Susan Orr, PhD (Claris Bio), and Anupam Dalal, MD (Acuta Capital), and Dr. Pravin Dugel, Chairman and CEO of Ocular Therapeutix, this session explores how macroeconomic and political shifts—such as RFK Jr.'s FDA rhetoric and rising interest rates—are influencing capital markets, regulatory confidence, and biotech strategy. With humor, candor, and deep expertise, the panel discusses: ...
2025-03-2831 min
OIS Podcast | Ophthalmology's leading PodcastBreaking Barriers in Sustained Drug Delivery: Michael O’Rourke on The Rob & Jai Show edition of the OIS PodcastIn this episode of The Rob & Jai Show, Michael O’Rourke, CEO of Re-Vana Therapeutics, joins Dr. Rob Rothman and Dr. Jai Parekh to explore the next-generation of sustained drug delivery in ophthalmology. With millions of intravitreal injections administered annually for retinal diseases like AMD, the need for longer-lasting, more effective treatments has never been greater.O’Rourke explains how Re-Vana’s proprietary hydrogel-based technologies are setting a new standard for biodegradable, sustained-release drug implants—offering six to twelve months of therapeutic coverage without the need for surgery. The discussion covers:🔹How Re-Vana’s EyeLief™ and OcuLief™ te...
2025-03-1413 min
OIS Podcast | Ophthalmology's leading PodcastA Visionary Approach to Uveitis: Tarsier Pharma’s Disruptive InnovationIn this OIS Podcast episode, host Dr. Robert Rothman sits down with Daphne Haim-Langford, PhD, Founder & CEO of Tarsier Pharma, and Ashley Kline, Chief Commercial Officer, to discuss their groundbreaking approach to uveitis treatment.Tarsier’s lead candidate, TRS01, is a first-in-class bio-inspired therapy designed to control inflammation without raising intraocular pressure, a major complication of steroid treatments. With a unique mechanism of action that modulates macrophages and reduces inflammation, this novel drug has the potential to redefine uveitis and glaucoma care. In this episode, you’ll learn:🔹 How Tarsier’s bio-inspir...
2025-02-1429 min
OIS Podcast | Ophthalmology's leading PodcastCompany Quick TakesCarey Powers caught up with five innovative companies at this years OIS XIV in San Diego, to discuss the latest advancements in ophthalmology on the OIS podcast.Topics included touchless laser therapy for presbyopia, extending the duration of intravitreal treatments, next-generation tear fluid testing, and new imaging methodologies for vitreoretinal conditions. Guests include:Alex Lopez, Chief Commercial Officer - Ace Vision GroupHouman Hemmati, MD, PhD, Co-Founder & Chief Medical Officer - Optigo BiotherapeuticsLeanne Lavriola, DO, MBA, President & CEO - InnSight TechnologyNir Katchinskiy, PhD, CEO & Co-Founder...
2024-12-0624 min
OIS Podcast | Ophthalmology's leading PodcastCelebrating 400 Episodes of OISDiscover the milestone 400th episode of the OIS podcast with Dr. Firas Rahhal and Dr. Robert Rothman, where they explore the impact of Ophthalmology Innovation Summit (OIS) on the investment ecosystem:Journey of OISRich InsightsCollaborationClinical MasteryLong-Term RelationshipsHumor and AdmirationFuture of OphthalmologyTune in to this episode for a blend of knowledge, inspiration, and laughter as they navigate the future of eye care innovation. Don’t miss out—listen now!
2024-07-1253 min
OIS Podcast | Ophthalmology's leading PodcastTodays Therapies are Not Sufficient: A Marketplace Ripe for InnovationThis week's OIS Podcast features a compelling panel discussion from the Dry Horizons Symposium co-presented by Ora and OIS, held on May 3 in Seattle. The panel, comprising leading experts in ophthalmology and dry eye research, covered essential topics in the field:🔹Advancements in Diagnostics: Insights into new tools and technologies for more accurate and reliable diagnosis of dry eye syndrome.🔹Regulatory Challenges: Discussion on the regulatory landscape and the hurdles faced in gaining approval for innovative treatments.🔹Artificial Intelligence in Dry Eye Management: Exploration of AI's potential to transform the management and treatment of dry eye throu...
2024-05-2436 min
OIS Podcast | Ophthalmology's leading Podcast5 Mistakes to Avoid in Biotech Investor Pitch DecksTune in to the latest episode of the Eye On Innovation podcast where Carey Powers dives into the dynamic world of biotech investor pitch decks with special guest Dr. Rob Rothman, Founding Partner of InFocus Capital Partners. Discover the top five mistakes to avoid when crafting your pitch deck and gain exclusive insights from Dr. Rothman's wealth of experience in ophthalmology and venture capital.In this episode, you'll learn:The importance of tailoring your pitch deck to specific investors.Strategies for keeping your pitch deck concise and engaging.Why it's crucial to address challenges, competition, and...
2024-03-0118 min
OIS Podcast | Ophthalmology's leading PodcastRevolutionizing Ophthalmic CareIn the latest episode of the OIS Podcast, host Dr. Robert Rothman engages in a captivating dialogue with Dr. Prasad Sunkara, CEO of Eyegenex.Key points discussed in the episode:Prasad's multifaceted background spanning agricultural sciences to pharmaceuticals.Eyegenex's pioneering work in gene and peptide therapies for ophthalmic conditions.The personal journey and insights driving Prasad's commitment to advancing ophthalmology.For a deep dive into this thought-provoking conversation, tune in to the OIS Podcast and explore the forefront of ophthalmic innovation.
2024-02-0337 min
OIS Podcast | Ophthalmology's leading PodcastMaximizing the Value of Your Board of DirectorsOIS Podcast host Carey Powers speaks with Dr. Adrienne Graves and Dr. Barbara Wirostko on 'Maximizing the Value of Your Board of Director' live from OIS XIII.Dr. Graves and Dr. Wirostko share valuable insights on:* Building effective boards* Significance of diversity* CEO and board member communications* Navigating decision-making* Board dynamics* Strategic collaboration This episode is a must-listen for CEOs and founders navigating the intricacies of leadership and strategic decision-making. Tune in now.
2024-01-0522 min
OIS Podcast | Ophthalmology's leading PodcastRevolutionizing Retina Care Beyond InjectionsIn this episode of the OIS Podcast, host Dr. Firas Rahhal, along with expert panelists, Dr. Robert Bhisitkul, Dr. Alan Franklin and Dr. Paul Karpecki at OIS XIII, takes listeners on a deep dive into the transformative landscape of oral therapies in retina treatment, challenging the conventional approach dominated by eye injections. Tune in as they explore the groundbreaking realm of oral treatments and shed light on their novelty in retinal care.The discussions are comprehensive, covering key aspects such as:• Novelty in Retina Treatment• Three-Step Improvement and Long-Term Vision Protection• Optimism for Preventio...
2023-12-1522 min
OIS Podcast | Ophthalmology's leading PodcastC-Suite Quick Takes: OIS Goes Behind the Scenes with Four Emerging Biotech CompaniesOIS Podcast host Carey Powers caught up with four ophthalmology execs and one principal investigator to talk about some of the most exciting developments in retina R&D.Her guests include:Houman David Hemmati, MD, PhD, Cofounder and Chief Medical Officer of Optigo Biotherapeutics Michael Tsipursky, MD, CEO and Cofounder of Revive BiotechMichael Singer, MD, Clinical Professor of Ophthalmology at University of Texas Health Science Center, Director of Clinical Research at Medical Center Ophthalmology Associates, and Principal Investigator for Unity Biotechnology’s BEHOLD trialSamarendra Mohanty, PhD, President and Cofounder; and Sulagna Bhattacharya, CEO and Cofounder of Nano...
2023-09-2220 min
OIS Podcast | Ophthalmology's leading PodcastCEO Quick TakesOIS Podcast host Carey Powers speaks with four CEOs from leading retina-focus companies to talk about all things innovation. Her guests include:• Kerrie Brady, BPharm, President and CEO of OcuTerra• Rich Small, CEO of NeuroTech Pharmaceuticals• Kester Nahen, PhD, CEO of Notal Vision• Brad Doerschuk, President and CEO of InFocus ClinicalOcuTerra is developing OTT166, a novel small molecule designed to treat diabetic retinopathy.The product is getting attention because it can deliver product to the retina via an eye drop application, said Kerrie Brady, BPharm, CEO of OcuTerra.The comp...
2023-09-0818 min
OIS Podcast | Ophthalmology's leading PodcastA Fast, Fun Future, with Warren Foust and Magda Michna, PhD, Staar SurgicalFor today’s episode, the newest addition to the OIS Podcast team, Carey Powers, sits down with the newest additions to the Staar Surgical team: Warren Foust, Chief Operating Officer; and Magda Michna, PhD, Chief Clinical, Regulatory, and Medical Affairs Officer.Starr has led the way in implantable lenses for over 40 years, but like many medical device companies, not many patients have heard of them.That’s changing now that Staar has doubled down on direct-to-consumer advertising. To date, they’ve secured collaborations with the Jonas Brothers, Peyton List, and NBA player Max Strus, among others...
2023-06-0916 min
OIS Podcast | Ophthalmology's leading PodcastHow Retina Physicians Can Use AI, With Natasa Jovic, RetinAINataša Jovic has led marketing strategies for retina products since the launch of Visudyne. Approved by the FDA in 2002, Visudyne was the first commercially available therapy to treat wet AMD. Today, Jovic applies her scientific background and retina experience to lead marketing and commercial operations for RetinAI, a software company that supports R&D initiatives.As a retina specialist, OIS podcast host Firas Rahhal, MD, wanted to know: what’s the deal with AI? How can it help me in my practice? Jovic provides insight.At present, the FDA has appr...
2023-05-1943 min
OIS Podcast | Ophthalmology's leading PodcastChanging the Glaucoma Monitoring ParadigmElevated intraocular pressure (IOP) is the only modifiable risk factor for glaucoma. The more IOP data, the better physicians can evaluate treatment impact, which is critical to preserving vision.Implandata Ophthalmic Products GmbH developed the eyemate® technology platform to fill that need. The implantable sensor, powered and read by a hand-held device, allows physicians to monitor IOP between visits.Implandata CEO and cofounder, Max Ostermeier, discussed the technology and the gap it fills with glaucoma specialist and OIS podcast host Rob Rothman, MD. Better IOP monitoring, they argue, can help change the paradigm of patient c...
2023-02-0331 min
OIS Podcast | Ophthalmology's leading PodcastSit-downs with Eight OIS XII All-StarsPodcast Description: More than 300 clinical thought leaders, pharma industry executives, and ophthalmology investors gathered recently in San Diego, CA, for OIS XII. In addition to announcing pivotal new data, presenters discussed drug and device innovations, advances in clinical trials, and how to gain or maintain a competitive edge in today’s market.For this week’s OIS Podcast, surgeon Ehsan Sadri, MD, co-founder of Visionary Ventures; and Sharon Bakalash, MD, PhD, founder and CEO of SB Strategic Development Consultants, sat down with an all-star cast of ophthalmology leaders. Here’s a preview of the cast...
2022-12-211h 09
OIS Podcast | Ophthalmology's leading PodcastSetting the Standards in ImagingFor more than 30 years, Heidelberg Engineering has set the standard in diagnostic imaging. Best known for imaging quality and optical coherence tomography (OCT) capabilities, Heidelberg focuses on innovation, customer service, and education. OIS Podcast host Sophia Pathai, MD, PhD, caught up with Heidelberg’s VP/head of corporate strategy Kfir Azoulay, as well as Heidelberg Engineering UK managing director Tosh Vadhia. From their respective locations in Heidelberg, Germany, and London, the two discussed what’s behind Heidelberg Engineering’s success. Although the company retains the feel of a close-knit family business, it aims...
2022-11-3028 min
OIS Podcast | Ophthalmology's leading PodcastFrom Leading Global R&D Teams to Funding StartupsScott Brun, MD, began his long career in pharma R&D leadership in the late 1990s, holding key roles at Abbott and AbbVie. Had he picked up a pencil with his right hand, his career may have taken a completely different turn.Dr. Brun earned his medical degree at Johns Hopkins University School of Medicine and completed a residency in ophthalmology at the Massachusetts Eye and Ear Infirmary. A leftie, Dr. Brun ultimately decided not to become ambidextrous. Instead, he joined Abbott as a pharmaceutical physician and began a fruitful career leading development across multiple therapeutic areas.
2022-11-2351 min
OIS Podcast | Ophthalmology's leading PodcastThe Potential of Entire-Eye OCT ImagingWhat if legendary ophthalmologist Don Gass, MD, had access to both optical coherence tomography (OCT) and artificial intelligence? One can only imagine the breakthroughs. Alex Walsh, MD, CEO of Envision Diagnostics and a retina specialist at Retina-Vitreous Associates in Los Angeles and vicinity, wants to bring Gassian interpretive capabilities to everyone in eye care. His company’s product, a binocular OCT with the potential to image the entire eye, could enable physicians and technicians to get objective, comprehensive data in six minutes. No waiting, no moving from room to room. The devic...
2022-11-1649 min
OIS Podcast | Ophthalmology's leading PodcastLaunching a Novel Dry Eye ProductThe Food and Drug Administration approved Tyrvaya (varenicline solution), a multidose nasal spray, to treat signs and symptoms of dry eye disease, about a year ago. Jeffrey Nau, PhD, MMS, CEO of Oyster Point Pharma, sat down with OIS Podcast host Paul Karpecki, OD, FAAO, to discuss the launch and his learnings over the year that was. Since then, about 62,000 Tyrvaya prescriptions have been written. It’s the first and only nasal spray designed for dry eye relief. Dr. Nau says refills and persistence numbers are strong. Dr. Kar...
2022-11-0923 min
OIS Podcast | Ophthalmology's leading PodcastThe Game ChangerRam Palanki, PharmD, VP of commercial strategy and operations for REGENXBIO, has been involved in the development and launch of at least two groundbreaking treatments: Lucentis (ranibizumab, Genentech/Roche) and Macugen (pegaptanib).If all goes well in clinical trials, Dr. Palanki could soon add one more to his extensive CV: a one-time gene therapy designed to treat age-related macular degeneration and diabetic retinopathy (DR). A master of back-of-the-eye product development and commercialization, Dr. Palanki sits down with OIS podcast host Firas Rahhal, MD, to discuss the history of retinal disease treatments and the potential of g...
2022-10-2655 min
OIS Podcast | Ophthalmology's leading PodcastSpotlight on OIS Israel at MIXiiiOIS has showcased dozens of ophthalmic leaders who are part of Israel’s thriving biotech and medtech spaces. This OIS Podcast features one of those leaders, who’s preparing for MIXiii Health-Tech.IL, the annual gathering for the life science and health tech industries in Israel. It’ll be held in Jerusalem November 9 and 10. And for the first time, OIS Israel will be part of it.Podcast host Rob Rothman, MD (also an OIS Israel cochair), talks to Tarsier Pharma founder and CEO Daphne Haim-Langford, PhD. Dr. Haim-Langford gives an update on her company’s Phase III trial fo...
2022-10-1922 min
OIS Podcast | Ophthalmology's leading PodcastRayner’s Tim Clover on KOLs and IOLsRayner is best known for its intraocular lenses (IOLs). It developed the world’s first IOL and is the sole manufacturer of IOLs in the UK. The company currently manufactures 1.3 million lenses a year, but there’s more to the story. Rayner’s portfolio also includes a delivery system, ophthalmic viscosurgical devices, drops, and a digital health platform that captures patient-reported outcomes.CEO Tim Clover discusses Rayner’s diversified focus and data-driven initiatives with OIS Podcast host Sophia Pathai, MD, PhD. They also talk about how Clover helped move the company in a new direction, which included tearing d...
2022-10-1231 min
OIS Podcast | Ophthalmology's leading PodcastGlenn Tookey’s Mission Against BlindnessAs head of Sight and Sound Technology, the largest supplier and distributor of technology and devices designed for visually-impaired and blind individuals, Glenn Tookey wouldn’t be disappointed if he went out of business. But until there are cures for all eye diseases, he remains a strong advocate for his customers. OIS Podcast host Rob Rothman, MD, kicked off a lively discussion with Tookey that covers the company’s beginnings four decades ago, how he evaluates new products, and how he plans to bring those products to more patients. Tookey’s tech industry career includes stints in teleco...
2022-09-2830 min
OIS Podcast | Ophthalmology's leading PodcastDemocratizing Cell TherapyAccording to the India Brand Equity Foundation, India is one of the top 12 destinations worldwide for biotech activity. Seed-stage venture capital firm Endiya Partners is a player in that space, investing in product startups solving global problems. One of its portfolio companies, Eyestem, is working to solve the problem of equal access to cell therapies. Its vision is to develop a scalable cell-therapy platform to treat incurable diseases and to democratize access to these therapies. With cell and gene therapies priced in the six figures, they’re out of reach for the majority of the global population.
2022-09-2139 min
OIS Podcast | Ophthalmology's leading PodcastGreat Minds Think DifferentlyMichael Chiang, MD, director of the National Eye Institute, spent more than 20 years in academic research. Now, he leads an organization that supports that research by funding more than 1,500 research and training grants for projects that address vision impairment and blindness.A pediatric ophthalmologist who’s board-certified in clinical informatics, Dr. Chiang remains intensely curious and generous. “I succeed when the vision research field succeeds,” he says in this OIS Podcast. With host Sophia Pathai, MD, PhD, Dr. Chiang lays out NEI’s recently unveiled strategic plan. The plan hints at where NEI plans to invest it...
2022-08-3138 min
OIS Podcast | Ophthalmology's leading PodcastMedTech Ophthalmology European VC PanelEuropean investment in ophthalmology MedTech is more opportunistic than strategic says Klaus Stockemann, managing partner of Peppermint VenturePartners in Berlin. With fewer venture capitalists focused on the market, they are more receptive to cold calls and impromptu pitches at medical conferences.That’s one of the many insights provided when new OIS Podcast host Sophia Pathai, MD, PhD, MPH caught up with three top-tier VCs who focus on ophthalmology devices and technology.After recalling their nonlinear backgrounds, Stockemann; Diana Saraceni, cofounder of Panakes Ventures (Milan); and Jennifer McMahon, a partner at Seroba VC (Dublin) discussed the...
2022-08-2446 min
OIS Podcast | Ophthalmology's leading PodcastOIS Retina 2022: How to Execute New Treatments for Dry AMD and GAA group of experts in AMD and geographic atrophy discussed two GA treatments in Phase III studies: Apellis’s pegcetacoplan and Iveric Bio’s Zimura.If approved, these therapies will potentially slow lesion growth and preserve vision in patients with GA. Because they require monthly or bimonthly injections, they may also dramatically increase workloads for already overtaxed retina specialists.David Boyer, MD, of Retina Vitreous Associates Medical Group, said they’ll adapt. Somehow. Tarek Hassan, MD, partner and director of vitreoretinal training at Associated Retinal Consultants, agreed, noting the current working model will have to change...
2022-08-0322 min
OIS Podcast | Ophthalmology's leading PodcastRoesky’s Quest: Durable Dry Eye TherapyIt started with a call. First, a call from Abbott led Christian Roesky to an industry role after completing his chemistry PhD in Germany. Next, came the call that would shape Roesky’s career—from Alcon, where he discovered eye care was his “everyday joy and passion.”The most pivotal call, however, came from Novaliq founder Bernhard Günther, who convinced Roesky to take his emerging startup to the next level. As managing director and CEO, Roesky has led Novaliq through development of a novel pipeline. Most notably, NOV03 (perfluorohexyloctane), a therapy des...
2022-05-1837 min
OIS Podcast | Ophthalmology's leading PodcastSeizing Opportunities with Novartis’ Dr. Jill HopkinsJill Hopkins, MD, didn’t plan to end up in a global leadership position at one of the world’s largest pharmaceutical companies. But she got there in 2021, when Novartis recruited her to serve as its SVP and global head of the ophthalmology development unit. Dr. Hopkins moved from academia to the clinic to industry, not by muscling her way in, but by exploring opportunities that sparked her interest and fueled her passion. At each steppingstone, she had a hand in some exciting developments. At Novartis, she leads drug development for its mid- to late-stage portfo...
2022-05-1131 min
OIS Podcast | Ophthalmology's leading PodcastBilal Khan, New World Medical, on Balancing Mission with ProfitabilityNew World Medical, maker of the Ahmed Glaucoma Valve, continues to innovate and maintain a steady pipeline without the cachet that comes with big-name partnerships.CEO Bilal Khan spoke with OIS podcast host Rob Rothman, MD, about assuming the lead role at New World Medical from founder Dr. A. Mateen Ahmed—Bilal’s father-in-law.While Dr. Ahmed and Bilal can “geek out” about glaucoma devices at the dinner table, it wasn’t that way 12 years ago. Bilal joined New World Medical in 2008 after working in finance and as an actuary. His lack of a medical background...
2022-04-2740 min
OIS Podcast | Ophthalmology's leading PodcastTreating ‘Lazy Eye’ with Screen Time NovaSight is tackling one of the biggest unmet needs in ophthalmology: pediatric amblyopia, otherwise known as “lazy eye.” It’s the leading cause of vision loss in children. And despite innovations in virtually every other eye condition, the most common amblyopia treatment has remained the eye patch.NovaSight’s CureSight is a binocular treatment that lets kids do their favorite on-screen activities—movies, YouTube videos, homework—while the device’s eye-tracking technology and three-dimensional image processing algorithms go to work. NovaSight recently presented positive top-line data and expects to receive Food and Drug Administration clearance in Q3. NovaSight’s...
2022-04-1340 min
OIS Podcast | Ophthalmology's leading PodcastTreating the Untreatable Using Your Own Patient Experience, with Diana Driscoll, ODEven the most experienced physicians encounter patients with conditions they can’t solve after multiple questions, tests, and treatments. Diana Driscoll, OD, has not only treated some of these patients successfully, she’s been one of them.On a trip to Costa Rica, Dr. Driscoll contracted a virus. Through 10 years of disability, she saw over 50 doctors, but still had no answer. Her son, who also contracted the virus, was bedridden for three years.Ultimately Dr. Driscoll was diagnosed with Postural Orthostatic Tachycardia Syndrome (POTS), an autonomic nervous system condition that causes symptoms ranging from lightheadedness to s...
2021-12-0822 min
OIS Podcast | Ophthalmology's leading PodcastMoving From Medicine to Industry, With David Tanzer and Kerrie BradyOIS podcast host Paul Karpecki, OD, FAAO, caught up with OcuTerra Therapeutics CEO and CMO, Kerrie Brady and David Tanzer, MD, to discuss OcuTerra’s novel small molecule integrin inhibitor. Preclinical data impressed David enough to resign from his CMO role at Novartis to help develop OTT166, a topical agent that meets a clear unmet need for patients with moderately severe to severe nonproliferative diabetic retinopathy (DR).The standard of care for patients with DR is to simply watch and wait. Intravitreal anti-VEGF injections are an option when complications occur, but those introduce significant patient burden....
2021-11-2429 min
OIS Podcast | Ophthalmology's leading PodcastIndustry Insights on the Glaucoma Market from OIS Glaucoma Innovation ShowcaseAdrienne Graves, PhD, former CEO of Santen, opened this panel discussion by reiterating a sentiment expressed by surgeons, innovators, and investors: we’re in the middle of a glaucoma renaissance. The release of new devices, instruments, and pharmaceuticals has led to improvements in surgical procedures and other treatment options that promise to improve the lives of glaucoma patients.For this week’s discussion, originally recorded for the OIS Glaucoma Innovation Showcase, Dr. Graves corralled four ophthalmology leaders to discuss what’s new and what’s next in glaucoma innovation, how their companies stay resilient through the SARS-CoV-2 pandemic...
2021-11-1042 min
OIS Podcast | Ophthalmology's leading PodcastFinding and Funding Assets in Retina, from OIS Retina@ASRSYou’ve got a game-changing product. They want to back innovators like you. What’s the secret to a happy marriage? More importantly, how to you get a first date?Recorded during OIS Retina@ASRS in San Antonio, Texas, five pharma and finance leaders discuss their current areas of interest, how to secure crucial series A funding, and what’s on the verge of disruption.Tune in today to discover:What’s hot in retina: Dr. Guerard believes multiple compounds can co-exist in the market. A researcher with a great science-backed idea may only...
2021-10-2041 min
OIS Podcast | Ophthalmology's leading PodcastThe Next Cycle of Retinal Surgery Innovation, with Stanley Chang, MDIf you want to predict eye surgery’s future, ask someone who pioneered the techniques used today.For this week’s podcast, Firas Rahhal, MD spoke with OIS Lifetime Innovator Award recipient Stanley Chang, MD, at the recent ASRS meeting about how the techniques he pioneered in the 1980s and 1990s have come full circle. Dr. Chang was the first to use perfluoropropane gas in the management of retinal detachments caused by scar tissue proliferation (PVR) on the retina. In the 1980s, he used SF6 and C3F8 gasses in vitreoretinal surgery. At the time, he wa...
2021-10-1313 min
OIS Podcast | Ophthalmology's leading PodcastSolving the Dry Eye Mystery, With Jeffrey Krall, NeurolensHow many patients have chronic dry eye symptoms that persist after you’ve tried every available therapy? They may have an imbalance between the peripheral visual tracking system and central fixation. Jeffrey Krall, OD, an optometrist in Mitchell, South Dakota, discovered the connection between this imbalance and the collection of symptoms associated with digital vision syndrome (DVS). He developed neurolens to test, diagnose, and treat those symptoms. A life-long tinkerer who comes from a long lineage of optometrists and ophthalmologists, Dr. Krall realized that many patients’ headaches, neck strain, and dry eye symptoms stemmed from an ove...
2021-10-0629 min
OIS Podcast | Ophthalmology's leading PodcastDeveloping a Clear Vision for a Clinical-Stage Company with Ben BergoVisus Therapeutics has more than doubled its team in the past two years, including the appointment of six senior leaders in June. CEO Ben Bergo grew that team as the company’s lead product, brimochol, a prescription eye drop designed to correct near vision loss caused by presbyopia, approached data readouts in Phase II clinical trials. As Visus prepares to move into Phase III studies later this year, OIS Podcast host Ehsan Sadri, MD, caught up with Ben to talk business and brimochol.Of the former, Ben shared how his career has progressed from spinning out...
2021-08-0427 min
OIS Podcast | Ophthalmology's leading PodcastThe Reversal of Age-Related Ophthalmic DisordersOur newest host, Rob Rothman, MD is shaking things up to bring fresh voices and ideas to the OIS Podcast. In what turned out to be the most fascinating podcast discussion to date, we had the privilege to speak with Bruce Ksander, Associate Professor of Ophthalmology at Harvard Medical School, who has also contributed to the highly-acclaimed book, Lifespan. Bruce opened our eyes, dropped our jaws, and completely blew our minds with research being conducted on reprogramming damaged cells to reverse the aging process. Tune in now for this mind-expanding and thought-provoking discussion around the fu...
2021-03-1050 min
OIS Podcast | Ophthalmology's leading PodcastBanishing Bureaucracy at BVIThis week on the OIS podcast, we have an exciting conversation between Ehsan Sadri, M.D. and Shervin Korangy, President and CEO of BVI Medical.Listen in as Shervin shares highlights of his professional evolution. He tells us how his unique path of living overseas and working on Wall Street has impacted how he thinks about building and managing teams, and how the impact extends to planning the next steps for BVI. His perspective is innovative, refreshing, and not to be missed!Would you like to be featured on our podcast? Visit OIS.net and...
2021-01-2733 min
OIS Podcast | Ophthalmology's leading PodcastOIS Industry Panel on Retina Start-upsThis week on the OIS podcast, host Firas Rahhal, MD, Partner at ExSight Ventures & Retina Vitreous Associates Medical Group facilitates an illuminating discussion on the topic of retina start-ups with a focus on providing tips to anyone interested in joining the retina space. Our guests include Andrew Stewart, AVP, US Commercial Retina of Allergan; Jay Duker, MD, Chief Strategic Scientific Officer, EyePoint Pharmaceuticals; Paul Hallen, VP & Global Head, Retina & Glaucoma, Alcon; and Ram Palanki, PharmD, SVP, Commercial Strategy & Operations, REGENXBIO.Listen in as this group shares advice on the topics of talent, asset quality, company st...
2020-12-1640 min
OIS Podcast | Ophthalmology's leading PodcastTim Clover, CEO of Rayner Talks About the Company’s Deep History in Ophthalmology, As Well As Their Future Plans For InnovationThis week the OIS Podcast hits a milestone with Episode 250. To mark the occasion, we feature a discussion with Tim Clover from the recent OIS European Innovation Showcase. Tim talks about his journey with Rayner and some significant changes he’s made since joining in 2014. Listen in (or watch) to learn more about Tim and his vision for Rayner’s expansion as a dominant player in eye-care.
2020-10-0728 min
OIS Podcast | Ophthalmology's leading PodcastListening to the Needs of the CustomerSeasoned start-up and medtech executive, Rob Thornhill joins us on this week’s OIS Podcast. Rob sold Tear Film to Alcon in 2018 and is back in the saddle as the CEO of Centricity Vision. Dr Sadri has Rob discuss the benefits of the Zepto device in delivering automated, precise, circular, and centered capsulotomies, how their business model evolved during COVID and the future direction for the company.
2020-08-2630 min
OIS Podcast | Ophthalmology's leading PodcastThe Lindstrom Method: Say ‘Yes’ to OpportunitiesIf there’s one podcast you listen to all year – this is it!Dick Lindstrom explains how saying “Yes” to opportunities, led him into an extremely gratifying and successful career in ophthalmology – which was the furthest thing from his plan to take over the family construction business.This episode is packed with gems of insights on building an academic practice and working with industry to balancing work and family. Ophthalmology’s leaders convene at the Ophthalmology Innovation Summits held several times a year. OIS Podcasts keeps the conversation going the entire year.
2020-08-0645 min
OIS Podcast | Ophthalmology's leading PodcastOIS Israel Panel Dives Into Global Industry Insights and InnovationThis week’s podcast is a panel discussion, “Industry Insights and Innovating Internationally,” held last month during the OIS Israel virtual program. The discussion was led by William J. Link, PhD, and included Laurent Attias, Alcon; Prabhu Velusami, MD, Johnson & Johnson London Innovation Center; Frank Chen, Santen Ventures; Richel Liu, Rimonci Capital; and serial entrepreneur Barak Azmon, MD. The panelists, based in different parts of the globe, share varying perspectives on where innovation happens, both geographically and structurally – that is, from the private, public, or corporate sectors. And they address the impact that Israel has on innovation in our f...
2020-07-0946 min
OIS Podcast | Ophthalmology's leading PodcastJohn Hovanesian, MD, on Business, Life, Trends, IOL Technology, and MoreThe OIS Podcast takes another step forward by posting on both iTunes and YouTube. Listen to or watch this entertaining exchange between host Ehsan Sadri, MD, and John Hovanesian, MD, as Dr. Hovanesian enlightens us with some of his principles in life and business, the pain points that his company, MDbackline, is addressing, future trends in patient care, and intraocular lens technologies that he’s bullish about.Dr. Hovanesian also supplies our Quote of the Week: “The enemy of innovation is high margins.”
2020-06-2531 min
OIS Podcast | Ophthalmology's leading PodcastOIS Retina Podcast: Interview with Serial Inventor Dr. Mark HumayunThis week marks the official launch of the OIS Retina Podcast with host Firas Rahhal, MD, interviewing world-renowned retina specialist and serial inventor Mark Humayun, MD, PhD, as his first guest. Here are a few impressive facts about Dr. Humayun:• He’s the director of the Dr. Allen and Charlotte Ginsburg Institute for Biomedical Therapeutics at the University of Southern California and co-director of the USC Roski Eye Institute.• He’s a professor of ophthalmology and a biomedical engineer.• He received numerous research awards, including the 2005 Innovator of the Year Award.• He was featured as one of the T...
2020-06-1833 min
OIS Podcast | Ophthalmology's leading PodcastIntroducing the OIS Retina Podcast!The big news for podcast listeners is the introduction of the OIS Retina Podcast. In this week’s episode you’ll get to meet the new host Firas Rahhal, MD, a Partner in Retina-Vitreous Associates Medical Group in Los Angeles and also a Partner in ophthalmology-focused ExSight Ventures.Dr. Rahhal and Ehsan Sadri, MD, host of the OIS Podcast, discuss what it’s like playing dual roles as physicians and investors, the current state of COVID-19, and some exciting retina innovations in the pipeline.
2020-06-1130 min
OIS Podcast | Ophthalmology's leading PodcastLeadership - How to Measure & Motivate in a Startup EnvironmentFor this episode of the OIS Podcast, we are sharing a panel discussion on Leadership which took place during the last OIS@AAO meeting in San Francisco.The focus of the conversation was on “How to Measure and Motivate in a Startup Environment” and featured some valuable insights from Adrienne Graves, Bernie Haffey, Ron Kurtz, Kirk Nielsen, and Andy Corley.Participants:Adrienne Graves, PhD, Independent Board Member - Nicox, IVERIC, Oxurion, Akorn, Greenbrook TMS, Surface PharmaBernie Haffey, President - Haffey & Co.Ron Kurtz, MD, President & CEO - RxSightKirk...
2020-04-3027 min
OIS Podcast | Ophthalmology's leading PodcastBobak Azamian CEO of Tarsus Addresses Unmet Needs in BlepharitisIn January of 2020, Tarsus raised $60 million Series B financing round to initiate Phase 2b/3 trial in the U.S. of their lead product TP-03 for Demodex blepharitis. In this episode, Bobby Azamian shares his background and path to ophthalmology, details on their clinical trials and practical advice for entrepreneurs.Interviewer:Ehsan Sadri, MDManaging PartnerVisionary MD Eye Laser instituteGuest:Bobak Azamian, MD, PhDCEOTarsusAre you interested in being an OIS Podcast guest or interested in presenting at one of our upcoming showcases?
2020-04-2324 min
OIS Podcast | Ophthalmology's leading PodcastRobert Dempsey New CEO of TearClearThis week’s OIS Podcast has breaking news on Robert Dempsey, the new CEO of TearClear, which came at the close of a Series B financing round. Listen to how he plans to take TearClear through the next stages of development.Interviewer:Ehsan Sadri, MDManaging PartnerVisionary MD Eye Laser instituteInterviewee:Robert DempseyCEOTearClearIf you are interested in being an OIS Podcast Guest or interested in being a Presenter at one of our upcoming showcases – Visi...
2020-04-1625 min
OIS Podcast | Ophthalmology's leading PodcastIndustry Insights into InnovationIn this episode of the OIS Podcast we are sharing more “best-of” content from the recent OIS@SECO. Summit Co-Chair Emmett T. Cunningham Jr., MD, PhD, MPH, engages vision industry Titans in a discussion around their latest innovations for both the Ophthalmic and Optometric markets.Participants:Glen Curran, VP, Anterior Segment Marketing, US Eye Care - AllerganJohn Ferris, VP & General Manager, Vision Care - Bausch + LombKurt Moody, OD, FAAO, Director, Ocular Surface Disease & Professional Strategy - Johnson & Johnson VisionAndy Pawson, President & GM, Global Vision Care - AlconPaul...
2020-04-1335 min
OIS Podcast | Ophthalmology's leading PodcastInnovating Around the GlobeIn this episode of the OIS Podcast we get to hear another panel discussion from the last OIS@AAO meeting in San Francisco. Emmett T. Cunningham Jr., MD, PhD, MPH, led a great discussion about Innovating Around the Globe with 2 international Venture Capitalists and 3 industry executives from Alcon, Santen and Novartis.Participants:Laurent Attias, SVP, Corporate Development Strategy, BD&L and M&A - AlconMichael Keyoung, MD, PhD, Managing Director & Head, North America - CBC GroupGiovanni Mariggi, Partner - MedicxiNaveed Shams, MD, PhD, Head, Global R&D, Chief...
2020-04-0631 min
OIS Podcast | Ophthalmology's leading PodcastCollaborative Care in Cataracts & Ocular Surface DiseaseIn this special episode of the OIS podcast, we have a discussion that took place during the recent OIS@SECO in Atlanta. Summit Co-Chairman, Paul Karpecki, OD, FFAO, set the stage with some staggering figures which led to an insightful conversation between two ODs and two MDs about Collaborative Care models and the benefits to both patients and practices.Participants:Thomas Chester, OD, Clinical Director - Cleveland Eye ClinicElise Kramer, OD, FAAO - Miami Contact Lens InstituteWilliam Trattler, MD, Director of Cornea - Center For Excellence In EyecareWilliam...
2020-03-3024 min
OIS Podcast | Ophthalmology's leading PodcastJ&J Vision’s Newly Appointed Worldwide President of Surgical, Mr. Warren Foust Meets with OIS PodcastThis past week OIS Podcast host, Dr. Ehsan Sadri had the opportunity to chat with J&J Vision’s newly appointed Worldwide President of Surgical, Mr. Warren Foust. In this episode Warren describes his background leading up to this new position. He also shares his “vision” for the organization moving forward, how they plan to enhance the customer experience and challenges to addressing unmet vision needs.REGISTER for our next ophthalmology conference today – OIS.net
2020-01-1413 min
OIS Podcast | Ophthalmology's leading PodcastJ&J’s Tom Frinzi Provides Updates on Innovation Efforts & MoreIn this episode of the OIS Podcast, Dr. Ehsan Sadri sits down with industry veteran Tom Frinzi to learn about Johnson & Johnson Vision Care’s current innovation efforts, the impact of cuts in reimbursements, growth drivers for the premium channel, and how his team is positioning the company to remain a leader in ophthalmology. And he provides some practical career advice.
2019-09-0420 min
OIS Podcast | Ophthalmology's leading PodcastMitro Opens Up About Aerie’s ProgramsTom Mitro of Aerie Pharmaceuticals opens up to OIS Podcast host Ehsan Sadri, MD, about the company’s key programs, including the Phase II trial of netarsudil ophthalmic solution for treatment of open-angle glaucoma.
2019-07-1024 min
OIS Podcast | Ophthalmology's leading PodcastCo-Chair James Thimons Walks Us Through the Highs and Even Highers of the First OIS@SECOWe visit again with James Thimons, OD, FAA, co-chair of OIS@SECO, the newest member of the OIS family. OIS@SECO convened last week in New Orleans, drawing more than 200 optometrists, entrepreneurs, and industry members. In this interview, Dr. Thimons, clinical director of Ophthalmic Consultants of Connecticut, walks us through the day. We also ask the dry eye expert his take on the recent fund-raising success of Oyster Pharmaceuticals, developer of a nasal spray that might help relieve the pain of that persistent condition.
2019-02-2730 min
OIS Podcast | Ophthalmology's leading PodcastDry Eye Coach Hauser Shares Insights on New Treatments, Social Media and Working with IndustryIn this encore OIS Podcast, well-known Dry Eye Coach discusses some of the strategies she’ll be sharing next month at OIS@SECO. Dr. Hauser will help lead off next month’s program at OIS@SECO. In this encore OIS Podcast, Dr. Hauser shares her insights on new dry eye treatments and offers advice for building an eye care practice through social media.
2019-01-1625 min
OIS Podcast | Ophthalmology's leading PodcastEric Donnenfeld, MD, Handicaps a Crowded Field in the Race to Develop the Next Dry Eye BlockbusterOIS Podcast visits with Eric Donnenfeld, MD, to review the field of innovative dry eye companies. We discuss the advances in drugs and devices, and Dr. Donnenfeld shares how new treatments are impacting ophthalmology, optometry, and combined practices. Few know the dry eye space as well.
2018-12-1235 min
OIS Podcast | Ophthalmology's leading PodcastChris Wroten, OD, Recalls Indirect Path into Eye Care, Sees Enormous Need for Upcoming OIS@SECOChris Wroten, OD, left a chemical engineering career to pursue his early love of optometry. This path followed a few detours and disasters (of the natural kind), but he credits the ophthalmology community for seeing him through some challenging times. Dr. Wroten, who is helping to organize the upcoming OIS@SECO in New Orleans, sees smooth roads ahead for innovation in eye care.
2018-12-0532 min
OIS Podcast | Ophthalmology's leading PodcastIn our 200th Episode, IDx Founder Shares Wisdom from Recent Success with the FDA, Venture InvestorsFirst, thanks to everyone who has helped make the OIS Podcast such a success. We at Healthegy – the producer of the OIS Podcast and events – are grateful for your support. In this week’s episode, we’re visited again by Michael Abramoff, MD, founder and CEO of IDx, the first company to obtain FDA approval for an AI diagnostic tool. In this interview, Dr. Abramoff explains how IDx-DR, an autonomous AI diagnostic for diabetic retinopathy, worked its way through the FDA. He also shares the process he used to raise $33 million from a syndicate of high-powered investors including 8VC, Optum Ve...
2018-11-1427 min
OIS Podcast | Ophthalmology's leading PodcastEyedaptic CEO Jay Cormier Lays Out Start-Up’s Vision for Augmented Reality Visual Restoration DeviceEyedaptic president and founder Jay Cormier tells OIS Podcast about his company’s augmented reality visual aid for people with late-stage age-related macular degeneration, which it expects to start beta testing soon. Watch his presentation at OIS Retina in Vancouver here.
2018-10-0321 min
OIS Podcast | Ophthalmology's leading PodcastJames Thimons, OD, Discusses Technology’s Positive Impact on Diagnosing and Treating Eye DiseaseIn this podcast, James Thimons, OD, delivers a comprehensive state of innovation in the treatment of eye disease. We recorded this interview in August immediately following the National Glaucoma Society meeting on Cape Cod. Thimons discusses the impact of artificial intelligence, MIGS, extensive pressure monitoring, and the potential of a device that should be familiar to OIS Podcast listeners. He also explains the potential of the Ocular Response Analyzer and the ICARE Home Tonometer in the monitoring, diagnosis, and treatment of glaucoma. 721903
2018-09-2033 min
OIS Podcast | Ophthalmology's leading PodcastGlaukos COO Calcaterra Lays out Pipeline Plans Following iStent inject OK, Reacts to CyPass RecallChris Calcaterra, COO of Glaukos, revisits the company’s recent good fortune at the FDA, which approved its second generation iStent inject. What’s next for Glaukos? Calcaterra walks OIS Podcast listeners through the company’s “Five in Five” pipeline. In a follow up to the interview, Calcaterra also reacts to Alcon’s decision to recall CyPass. How will this impact Glaukos? Does he have any concerns?
2018-09-1324 min
OIS Podcast | Ophthalmology's leading PodcastDoug Foster, Chief Strategy Officer of Verana Health, Explains Plans to Replicate IRIS PartnershipVerana Health, once known as DigiSight, has been working to make AAO’s EHR database available to commercial partners. Now, the company plans to expand that model in healthcare. In this week’s OIS Podcast, Doug Foster, the new chief strategy officer, explains how the company plans to use the AAO relationship as a template to work with other societies. He also talks about Verana’s new CEO Miki Kapoor (heard on this Breaking Health Podcast) and the new $30 million round of financing led by GV, the venture arm of Alphabet Inc.
2018-08-0829 min
OIS Podcast | Ophthalmology's leading PodcastDid You Miss OIS Retina (or Just Miss Being in Vancouver?) Hear Highlights from the Meeting FloorOIS Podcast Host Tom Salemi Speaks with Investors Greg Grunberg, MD, and Firas Rihhal, MD, as well as OIS Contributors Richard Mark Kirkner and Bérénice Magistretti about some of the key takeaways for investors, physicians and patients.
2018-08-0231 min
OIS Podcast | Ophthalmology's leading PodcastSkimming the Ocular Surface with TFOS’ Amy Gallant Sullivan and Purdue Researcher Chi Hwan LeeThis week the OIS Podcast skims the ocular surface with two interviews. First, we talk with Amy Gallant Sullivan, executive director of the Tear Film and Ocular Surface Society (TFOS), about her organization’s work in raising awareness about ocular surface disease and dry eye. TFOS and the Alliance for Eye and Vision Research sponsored a congressional briefing on dry eye in Washington, DC, last week. Then, Purdue University researcher Chi Hwan Lee, PhD, explains why Google and Alcon inspired him and his team to develop the glucose-sensing contact lens. What’s next for the early stage project?
2018-07-1838 min
OIS Podcast | Ophthalmology's leading PodcastOyster Point Pharma CEO Nau Takes a Deeper Dive into Just-Released PEARL Trial ResultsWith Oyster Point Pharma announcing results from the Phase IIb PEARL study, company president and CEO Jeffrey Nau, PhD, talks with OIS Podcast about what the findings mean for OC-02, a nicotinic acetylcholine receptor agonist the company is developing to treat the signs and symptoms of dry eye disease. The study met both primary endpoints by showing a statistically significant improvement in signs and symptoms compared with control. Top-line data from the study will be presented this weekend at the American-European Congress of Ophthalmic Surgery Summer Symposium in Deer Valley, UT. OC-02 is delivered as a nasal spray and stimulates...
2018-07-1223 min
OIS Podcast | Ophthalmology's leading PodcastSurgeon/Engineer Steve Charles Has Advice for Aspiring Inventors: Never Stop Learning; Dump NetflixAsk renowned vitreoretinal surgeon and inventor Steve Charles, MD, if he considers himself a surgeon or engineer first and he'll answer - both. In this OIS Podcast, Dr. Charles says the terms "inventor" and "innovator" aren't job titles. Innovation and inventing are what you get when insightful people commit themselves to a lifetime of learning in engineering and medicine. Dr. Charles gives his view of the future of innovation in the US. Here's a hint. You won't need to wear shades.
2018-06-1335 min
OIS Podcast | Ophthalmology's leading PodcastOIS Podcast Update on Dry Eye and MGD - What's Up at J&J, Oyster Point and Tear Film Innovations?Hear the latest from OIS events as the OIS Podcast connects with Tom Frinzi and Joseph Boorady, the new leadership at Johnson & Johnson Vision. Next, CEO Jeffrey Nau introduces Oyster Point to OIS while Rob Thornhill, CEO of Tear Film Innovations, explains his company's treatment for Meibomian Gland Disorder.
2018-05-2315 min
OIS Podcast | Ophthalmology's leading PodcastOIS Podcast Finds Out What's Next for Nicox and Zeiss in Two Talks with Michele Garufi and Jim MazzoNicox has had quite a year, bringing two new ophthalmology projects to the market through partnerships with Bausch + Lomb and Eyevance Pharmaceuticals. So what's next for the global company? CEO Michele Garufi provides answers. James V. Mazzo, global president for Carl Zeiss Meditec's Strategic Business Unit Ophthalmic Devices, sits down with us at OIS@ASCRS to talk about his three years at the company and what the future might bring.
2018-05-1629 min
OIS Podcast | Ophthalmology's leading PodcastOIS Podcast Talks Fund-raising with Avedro's Reza Zadno, Innovation with Allergan's Bill MeuryThe OIS Podcast returns with a double feature. Avedro CEO Reza Zadno talks about the company's latest $25 million round. Also, Bill Meury, CCO of Allergan, visits at OIS@ASCRS to talk about the company's appetite for acquiring innovation. You can watch our April 12 interview with Dr. Zadno at OIS@ASCRS here. You can also watch the podcast interview with Bill Meury, which was conducted at OIS@ASCRS.
2018-05-1025 min
OIS Podcast | Ophthalmology's leading PodcastShire's Dempsey Highlights Global Leader's Early Bet in Optometry, Role in Upcoming OIS LaunchRobert Dempsey, head of Shire's global ophthalmics franchise, will be a headliner at next week's OIS Launch Dry Eye Innovation Dinner held during the SECO 2018 meeting. In this podcast, Dempsey discusses the importance optometrists are playing in Shire's strategy
2018-02-2314 min
OIS Podcast | Ophthalmology's leading PodcastPart II: OIS Co-chair Emmett Cunningham, Jr. Delivers Annual Overview on the State of OphthalmologyIn part one of a two-part podcast, OIS co-chair and Clarus Funds managing director Emmett Cunningham, Jr., MD, PhD, MPH, delivers a 360-degree review of ophthalmology’s more promising pipelines. To download a copy of an extended version of the Year in Review report delivered at OIS@AAO click here.
2017-12-0626 min
OIS Podcast | Ophthalmology's leading PodcastOIS Co-chair Emmett Cunningham, Jr., MD. Delivers Annual Overview on the State of OphthalmologyIn part one of a two-part podcast, OIS co-chair and Clarus Funds managing director Emmett Cunningham, Jr., MD, delivers a 360-degree review of ophthalmology’s more promising pipelines.
2017-11-2930 min
OIS Podcast | Ophthalmology's leading PodcastOIS Co-Chair Emmett Cunningham Walks through the Upcoming OIS@AAO Agenda, Reveals New Ways to EngageOIS co-chair Emmett T. Cunningham Jr., MD, PhD, MPH, talks about OIS’ evolution over nearly a decade of meetings. The addition of Breakfast Breakout Sessions and Master Classes has opened opportunities for speakers and attendees. Dr. Cunningham, a partner at Clarus, also walks us through the agenda of next week’s OIS@AAO in New Orleans. This year’s agenda includes several new topics and formats as well as the return of a familiar face on stage.
2017-11-0126 min
OIS Podcast | Ophthalmology's leading PodcastOIS@ASRS Co-Chairs Give High Marks and Hopes for Innovators Looking at the Back of the EyeOIS@ASRS co-chairs Emmett Cunningham Jr., MD, Mark S. Humayun, MD, PhD, and John Pollack, MD, took a few minutes to share their thoughts on the second OIS@ASRS. Dr. Humayun, the outgoing ASRS president, shares details on his next undertaking – finding a way to measure the value of vision protection. Meanwhile, Dr. Pollack highlights one of his priorities after taking over as ASRS president.
2017-08-1620 min
OIS Podcast | Ophthalmology's leading PodcastShould You Be at OIS@ASRS on Thursday? Take an Insider Look at the Agenda with Emmett CunninghamOIS Co-chair Emmett T. Cunningham Jr., MD, PhD, MPH, managing director, Clarus Funds, walks us through the agenda of Thursday’s OIS@ASRS. What areas of retina will dominate the headlines for the next 12 months?
2017-08-0820 min
OIS Podcast | Ophthalmology's leading PodcastCOO Tom Mitro Discusses Aerie’s Preparation for Rhopressa Launch, Updates OIS@ASCRS on PipelineIn this interview, Tom Mitro, COO of Aerie Pharmaceuticals, says new hires brought on to prepare for likely commercial sale of Rhopressa bring new life and energy into a company hitting its stride. He also provides to OIS@ASCRS an update on the firm’s glaucoma pipeline.
2017-05-3114 min
OIS Podcast | Ophthalmology's leading PodcastIn an Insightful Wrap-up, OIS Co-chairs Share the Top Takeaways from another Successful OIS@ASCRSEmmett Cunningham, MD, Gil Kliman, MD, and Bill Link, PhD, co-chairs of OIS, talk about device funding, myopia, and the Masters of the Industry following a successful OIS@ASCRS.
2017-05-0715 min
OIS Podcast | Ophthalmology's leading PodcastCan OIS Help Make Myopia Great Again? Co-chair Kliman Discusses Inventive New Panel, OpportunitiesGil Kliman, managing director at InterWest Partners, reviews his role at the upcoming OIS@ASCRS, including an overview of anterior segment innovation and a discussion on lower myopia.
2017-04-2709 min
OIS Podcast | Ophthalmology's leading PodcastOIS Co-Chair Bill Link Walks Us Through OIS@ASCRS May 4 Agenda and Introduces Flying L PartnersOIS Co-Chair William J. Link, PhD walks us through OIS@ASCRS’ May 4 agenda, which takes place in LA. Link also explains why he Andy Corley and Richard Lindstrom, MD, formed Flying L Partners. Hear about the firm’s most recent investment.
2017-04-0521 min
OIS Podcast | Ophthalmology's leading PodcastOIS Editorial Roundtable: What Impact Will a Trump Administration Have on Ophthalmology?The election of Donald Trump had an immediate impact on our OIS Index. OIS writers and editors dig deeper, discussing what the long-term impact could be on drug prices, regulation and the ophthalmology’s bottom line?
2016-11-1628 min
OIS Podcast | Ophthalmology's leading PodcastLive (sort of) from Chicago: OIS Podcast Brings You the Voices of OIS@AAOThis OIS Podcast brings a bit of OIS@AAO to your laptop and smartphone. Hear from a few of the leaders in ophthalmology including executives from Allegro Ophthalmics, Avedro, LacriScience, Ocular Therapeutics, Opthea, and Sightline Surgical.
2016-10-2019 min
OIS Podcast | Ophthalmology's leading PodcastIntroducing Our Newest Tool – the OIS IndexOIS has partnered with Michael Lachman of EyeQ Research to create a vital new stock index of ophthalmology companies. This new tool will enable us to deliver broader insights and stronger analysis of our exciting sector.
2016-10-1216 min
OIS Podcast | Ophthalmology's leading PodcastOIS Founder & Co-Chair Emmett Cunningham Jr. Tells Us What to Watch for Next Week in ChicagoEmmett T. Cunningham Jr., MD, PhD, MPH, partner at Clarus, runs through the revamped agenda of OIS@AAO. Go to OIS.net to view the agenda and to register.
2016-10-0516 min
OIS Podcast | Ophthalmology's leading PodcastLive (sort of) from Copenhagen: OIS Podcast Hits the High Points of ESCRS and EuRetinaCopenhagen was the epicenter of the ophthalmology last week as several clinical meetings including ESCRS, EuRetina, and EuCornea convened in the city. OIS Podcast reports from the hallways, meeting spaces, and exhibition floor.
2016-09-1556 min
OIS Podcast | Ophthalmology's leading PodcastLive from the Floor of OIS@ASRS: Co-Chair Bill Link on What Made the Day Work So WellLive from the floor of OIS@ASRS: Co-chair Bill Link on what made the day work so well. The marriage of OIS with ASRS started strong. Hear ophthalmology veteran Bill Link on why the back of the eye is an enormous opportunity for companies, investors, and physicians.
2016-08-1114 min
OIS Podcast | Ophthalmology's leading PodcastWhat the Heck Happened at OIS@ASCRS?The fifth OIS@ASCRS delivered highlights on diagnostics, glaucoma devices, and What The Future of ophthalmology might bring. OIS Podcasts will provide a quick review of the day for those who couldn’t make it (or simply had overstuffed their meeting calendar in New Orleans).
2016-05-1522 min
OIS Podcast | Ophthalmology's leading PodcastEmptying the OIS Reporter’s Notebook After OIS@AAOOIS Correspondents Michelle Dalton and Richard Kirkner pool their insights on the most compelling sights and insights of OIS, Subspecialty Day and AAO. The two scribes opine on exiting new disease targets, advances in drug delivery, the penetration of digital technology and why the `Pfizergan’ deal makes sense for ophthalmology.
2015-12-0931 min
OIS Podcast | Ophthalmology's leading PodcastA Rundown of a Record-setting OISThe Ophthalmology Innovation Summit hit it big in Las Vegas prior to the industry’s American Academy of Ophthalmology Annual Meeting. With close to 1,000 registered attendees, OIS@AAO brought innovators together with both public and private investors as well as corpo-rate leaders of our dynamic sector. OIS Podcast walks through the agenda, hitting upon the highlights that include comments from OIS and industry leaders.
2015-11-1923 min
OIS Podcast | Ophthalmology's leading PodcastCelniker Gets Eleven Bio Ready For OIS and Conference SeasonEleven Biotherapeutics last spring issued some disappointing news when its leading project, EBI-005 didn’t fare well in a Phase III trial for Dry Eye. However, the company’s AMP-Rx platform is chugging along and its EBI-005 is making progress against other conditions including allergic conjunctivitis. CEO and President Abbie C. Celniker, PhD, updates OIS Podcast listeners on the pipeline and shares how the company is preparing for the oncoming conference season, which starts with OIS.
2015-11-0922 min